An act relating to repeal of authorization of overdose prevention centers
H.39 would repeal Vermont’s existing statutory authorization for overdose prevention centers. Under current law, these centers may operate as supervised spaces where people can consume preobtained drugs while receiving harm-reduction services such as sterile supplies, drug checking, overdose monitoring and reversal, first aid, referrals to treatment and social services, and education on safer use and disease prevention. The bill removes the section of law that defines these centers, directs the Department of Health to develop operating guidelines, and grants immunity protections to participants, staff, property owners, operators, and certain public employees involved with approved centers.
If enacted, the bill would eliminate the legal framework that shields overdose prevention center participants and related parties from criminal, civil, administrative, and property-seizure consequences tied to regulated-drug possession and related conduct when acting in good faith under the program. It would also end the reporting requirements for operators and the statutory rule that such centers are not treated as health care facilities for certain purposes. The bill is set to take effect July 1, 2025.
The bill would amend 18 V.S.A. § 4256 by repealing the state’s authorization for overdose prevention centers and, with it, the associated immunity provisions, operating-guideline requirements, and annual public reporting obligations. This would change the legal status of supervised drug-consumption sites in Vermont by removing express statutory protection for users, staff, operators, property owners, and certain government employees, and by eliminating the Department of Health’s role in establishing program standards for these centers.
Based on the bill text and available context, the measure appears to be framed as a repeal of a harm-reduction policy rather than an expansion of it, suggesting a more restrictive approach to regulated-drug policy. No committee transcript or vote history was provided, so there is no recorded debate or roll-call evidence here to indicate broader legislative support or opposition. The bill’s introduction by a large group of representatives suggests the issue has attracted notable interest among sponsors.
The central point of contention is whether Vermont should continue to authorize overdose prevention centers as a public-health and harm-reduction tool. Supporters of repeal are likely to argue that the state should not provide legal immunity for spaces where illegal drug use occurs, while opponents would likely emphasize overdose prevention, linkage to treatment, and reduced public-health harms such as HIV, hepatitis, and fatal overdoses. The bill’s removal of protections for operators, landlords, and public employees also raises concerns about legal exposure and the practical viability of any such centers.